Overview

Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging

Status:
Recruiting
Trial end date:
2028-06-30
Target enrollment:
Participant gender:
Summary
The purpose of the study is to see if a new group of imaging tests can help identify response to stage IV HER2+ breast cancer before treatment.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Alabama at Birmingham